Clinical trial
COVID-19 Antibody Responses In Cystic Fibrosis
NCT05158829 is registered in ClinicalTrials.gov with Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- COVID-19 Antibody Responses In Cystic Fibrosis
- Lead sponsor
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 1, 2022
- Completion date
- May 31, 2024
- Enrollment
- 250 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.